Advanced search
Publication Cover
Leukemia & Lymphoma Volume 19, 1995 - Issue 5-6
Submit an article Journal homepage
23
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Clinical and Cell Biological Features Related to Cellular Drug Resistance of Childhood Acute Lymphoblastic Leukemia Cells

G. J. L. Kaspers Department of Pediatrics, Free University Hospital, Amsterdam
,
R. Pieters Department of Pediatrics, Free University Hospital, Amsterdam
,
C. H. Van Zantwijk Department of Pediatrics, Free University Hospital, Amsterdam
,
E. R. Van Wering Dutch Childhood Leukemia Study Group, The Hague, The Netherlands
&
A. J. P. Veerman Department of Pediatrics, Free University Hospital, Amsterdam; Dutch Childhood Leukemia Study Group, The Hague, The Netherlands
Pages 407-416 | Received 29 Dec 1994, Published online: 01 Jul 2009

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Rabih Said & Apostolia Maria Tsimberidou. (2014) Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies. Expert Opinion on Drug Metabolism & Toxicology 10:3, pages 483-494.
Read now
Monika M. Trebo, Andishe Attarbaschi, Georg Mann, Milen Minkov, Rosi Kornmüller & Helmut Gadner. (2005) Histiocytosis following T-acute lymphoblastic leukemia: A BFM study. Leukemia & Lymphoma 46:12, pages 1735-1741.
Read now
Yoav Messinger & Fatih M. Uckun. (1999) A Critical Risk-Benefit Assessment Argues Against the Use of Anthracyclines in Induction Regimens for Newly Diagnosed Childhood Acute Lymphoblastic Leukemia. Leukemia & Lymphoma 34:5-6, pages 415-432.
Read now

Articles from other publishers (24)

Sheila Xinxuan Soh, Joshua Yew Suang Lim, John W. J. Huang, Nan Jiang, Allen Eng Juh Yeoh & S. Tiong Ong. (2014) Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia. PLoS ONE 9:8, pages e103435.
Crossref
Fung Kwong-Lam & Chan Godfrey Chi-Fung. (2013) Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment. Experimental Hematology & Oncology 2:1.
Crossref
Maria A.A. Cortez, Carlos A. Scrideli, José A. Yunes, Elvis T. Valera, Sílvia R.C. Toledo, Patrícia C.B. Pavoni‐Ferreira, Maria L.M. Lee, Antônio S. Petrilli, Silvia R. Brandalise & Luiz G. Tone. (2009) mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death. Pediatric Blood & Cancer 53:6, pages 996-1004.
Crossref
J.F. Mata, C.A. Scrideli, R.P. Queiroz, B.O. Mori, M. Emerenciano, M.S. Pombo-de-Oliveira & L.G. Tone. (2006) Cytosine arabinoside-metabolizing enzyme genes are underexpressed in children with MLL gene-rearranged acute lymphoblastic leukemia. Brazilian Journal of Medical and Biological Research 39:11, pages 1417-1423.
Crossref
M.L. Den BoerD.O. HarmsR. PietersK.M. KazemierU. GöbelD. KörholzU. GraubnerR.J. HaasN. JorchH.J. SpaarG.J.L. KaspersW.A. KampsA. Van der Does-Van den BergE.R. Van WeringA.J.P. VeermanG.E. Janka-Schaub. (2003) Patient Stratification Based on Prednisolone-Vincristine-Asparaginase Resistance Profiles in Children With Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 21:17, pages 3262-3268.
Crossref
Yaddanapudi Ravindranath. (2003) Recent advances in pediatric acute lymphoblastic and myeloid leukemia. Current Opinion in Oncology 15:1, pages 23-35.
Crossref
G. J. L. Kaspers & A. J. P. Veerman. 2003. Chemosensitivity Testing in Oncology. Chemosensitivity Testing in Oncology 196 220 .
Ellis Groninger, Tiny Meeuwsen-de Boer, Pauline Koopmans, Donald Uges, Wim Sluiter, Anjo Veerman, Willem Kamps & Siebold de Graaf. (2002) Pharmacokinetics of Vincristine Monotherapy in Childhood Acute Lymphoblastic Leukemia. Pediatric Research 52:1, pages 113-118.
Crossref
Christian WuchterVelia RuppertMartin SchrappeBernd DörkenWolf-Dieter LudwigLeonid Karawajew. (2002) In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia. Blood 99:11, pages 4109-4115.
Crossref
WA Kamps, JPM Bökkerink, FGAJ Hakvoort-Cammel, AJP Veerman, RS Weening, ER van Wering, JF van Weerden, J Hermans, R Slater, E van den Berg, WG Kroes & A van der Does-van den Berg. (2002) BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991–1996). Leukemia 16:6, pages 1099-1111.
Crossref
Antoinette Y. N. Schouten-van Meeteren, Paul van der Valk, Hans C. van der Linden, Annette C. Moll, Saskia M. Imhof, Dieuwke R. Huismans, Anne H. Loonen & Anjo J. P. Veerman. (2001) Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay. Cancer 92:11, pages 2933-2940.
Crossref
V. de Haas, C.E. van der Schoot & H. van den Berg. (2001) Risk assessment in ALL in children: A focus on PCR-based techniques for MRD detection. Annals of Oncology 12:5, pages 587-592.
Crossref
H. van den Berg & J. van der Lelie. (2000) Acute lymphoblastic leukaemia in puberty and adolescence. Annals of Oncology 11:11, pages 1375-1379.
Crossref
Michael DördelmannAlfred ReiterArndt BorkhardtWolf-Dieter LudwigNicolai GötzSusanne ViehmannHelmut GadnerHansjörg RiehmMartin Schrappe. (1999) Prednisone Response Is the Strongest Predictor of Treatment Outcome in Infant Acute Lymphoblastic Leukemia. Blood 94:4, pages 1209-1217.
Crossref
M. L. Den Boer, P. Kapaun, R. Pieters, K. M. Kazemier, G. E. Janka‐Schaub & A. J. P. Veerman. (2005) Myeloid antigen co‐expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance . British Journal of Haematology 105:4, pages 876-882.
Crossref
C Gidding. (1999) Vincristine revisited. Critical Reviews in Oncology/Hematology 29:3, pages 267-287.
Crossref
G. J. L. Kaspers, Ch. M. Zwaan, R. Pieters & A. J. P. Veerman. 1999. Drug Resistance in Leukemia and Lymphoma III. Drug Resistance in Leukemia and Lymphoma III 415 421 .
R. Pieters, G. J. L. Kaspers, N. L. Ramakers-van Woerden, M. L. den Boer, M. G. Rots, Ch. M. Zwaan, E. G. Haarman & A. J. P. Veerman. 1999. Drug Resistance in Leukemia and Lymphoma III. Drug Resistance in Leukemia and Lymphoma III 391 395 .
Z. Karakaş, L. Ağaoğlu, S. Erdem, G. Yanikkaya Demirel, M. Arasa, F. Süzergöz, G. Deniz, S. Anak & G. Gedikoğlu. 1999. Drug Resistance in Leukemia and Lymphoma III. Drug Resistance in Leukemia and Lymphoma III 21 28 .
G.J.L. KaspersR. PietersC.H. Van ZantwijkE.R. VanWeringA. Van Der Does-Van Den BergA.J.P. Veerman. (1998) Prednisolone Resistance in Childhood Acute Lymphoblastic Leukemia: Vitro-Vivo Correlations and Cross-Resistance to Other Drugs. Blood 92:1, pages 259-266.
Crossref
M.L. den BoerR. PietersK.M. KazemierM.M.A. RottierC.M. ZwaanG.J.L. KaspersG. Janka-SchaubG. HenzeU. CreutzigR.J. ScheperA.J.P. Veerman. (1998) Relationship Between Major Vault Protein/Lung Resistance Protein, Multidrug Resistance-Associated Protein, P-Glycoprotein Expression, and Drug Resistance in Childhood Leukemia. Blood 91:6, pages 2092-2098.
Crossref
G. J. L. Kaspers, M. Zwaan, U. Creutzig, J. Ritter, M. M. A. Rottier, R. Pieters & A. J. P. Veerman. 1998. Acute Leukemias VII. Acute Leukemias VII 491 495 .
R. Pieters, E. Klumper, G.J.L. Kaspers & A.J.P. Veerman. (1997) Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia. Critical Reviews in Oncology/Hematology 25:1, pages 11-26.
Crossref
G. Henze. (1997) Childhood acute lymphoblastic leukaemia. European Journal of Cancer 33:1, pages 8-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.